135 related articles for article (PubMed ID: 4808456)
1. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA
J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
[No Abstract] [Full Text] [Related]
2. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
[TBL] [Abstract][Full Text] [Related]
3. [Studies on hypolipidemic agents. IV. Syntheses and hypolipidemic activities of 4-substituted phenoxyisobutyric acid derivatives (author's transl)].
Miyoshi F; Fukami H; Sako Y
Yakugaku Zasshi; 1974 Sep; 94(9):1061-9. PubMed ID: 4476773
[No Abstract] [Full Text] [Related]
4. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.
Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR
J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517
[TBL] [Abstract][Full Text] [Related]
5. Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activity.
Moussavi Z; Depreux P; Lesieur D; Cotelle N; Sauzieres J; Plancke MO; Fruchart JC
Farmaco; 1991 Feb; 46(2):339-55. PubMed ID: 1859587
[TBL] [Abstract][Full Text] [Related]
6. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
7. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
8. Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.
Watanabe T; Hayashi K; Yoshimatsu S; Sakai K; Takeyama S; Takashima K
J Med Chem; 1980 Jan; 23(1):50-9. PubMed ID: 7359513
[TBL] [Abstract][Full Text] [Related]
9. Hypolipidemic substituted 1,3-benzodioxole-2-carboxylates.
Grisar JM; Claxton GP; Parker RA; Palopoli FP; Kariya T
J Med Chem; 1974 Jul; 17(7):721-5. PubMed ID: 4836402
[No Abstract] [Full Text] [Related]
10. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
Newman HA; Heilman WP; Witiak DT
Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
[No Abstract] [Full Text] [Related]
11. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
12. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
[TBL] [Abstract][Full Text] [Related]
13. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative.
Wada S; Koizumi M; Sasahara K; Neichi T; Nakakimura H; Onoda F; Hata SI
Atherosclerosis; 1981; 40(3-4):263-71. PubMed ID: 7332605
[TBL] [Abstract][Full Text] [Related]
14. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
[TBL] [Abstract][Full Text] [Related]
15. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate.
Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA
J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693
[TBL] [Abstract][Full Text] [Related]
16. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
[TBL] [Abstract][Full Text] [Related]
17. Hepatic effect of two hypolipidemic drugs in rats.
Magnusson G; Magnusson O
Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
[TBL] [Abstract][Full Text] [Related]
18. Newer hypolipidemic compounds.
Kritchevsky D
Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139
[No Abstract] [Full Text] [Related]
19. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
Lewis NJ; Feller DR; Poochikian GK; Witiak DT
J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
[No Abstract] [Full Text] [Related]
20. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
Parker RA; Kariya T; Grisar JM; Petrow V
J Med Chem; 1977 Jun; 20(6):781-91. PubMed ID: 406395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
